Ignite Creation Date:
2025-12-24 @ 1:21 PM
Ignite Modification Date:
2026-01-25 @ 10:06 PM
Study NCT ID:
NCT04160195
Status:
TERMINATED
Last Update Posted:
2022-02-15
First Post:
2019-11-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin Lymphoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-11
Completion Date Type:
ACTUAL
First Submit Date:
2019-11-08
First Submit QC Date:
None
Study First Post Date:
2019-11-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-12-16
Results First Submit QC Date:
None
Results First Post Date:
2022-02-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-26
Last Update Post Date:
2022-02-15
Last Update Post Date Type:
ACTUAL